{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:04:50Z","timestamp":1791770690675,"version":"4.3.4"},"reference-count":144,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CBF-2025-1"],"award-info":[{"award-number":["CBF-2025-1"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder increasingly recognized as a systemic inflammatory condition with significant neurological effects. Growing evidence shows that chronic low-grade inflammation (CLGI), insulin resistance, and metabolic imbalance contribute to cognitive decline and the development of neurodegenerative diseases like Alzheimer\u2019s and Parkinson\u2019s. Toll-like receptor 2 (TLR2), a critical pattern-recognition receptor of the innate immune system, has emerged as an essential molecular link between metabolic dysfunction and neuroinflammation and neuronal damage. This review summarizes current experimental, clinical, and translational evidence on the role of TLR2 in T2DM-related inflammation, mitochondrial dysfunction, lipid imbalance, insulin resistance, and blood\u2013brain barrier (BBB) issues. We explore how ongoing TLR2 activation by internal danger signals and metabolic stressors maintains systemic inflammation and fuels neuroimmune responses via microglial activation and cytokine release, thereby accelerating neurodegenerative processes. Additionally, we discuss new therapeutic strategies targeting TLR2 signaling, including drugs, dietary supplements, and the repurposing of antidiabetic medications with neuroprotective effects. By combining immunometabolic and neurodegenerative pathways, this review highlights TLR2 as a promising target for preventing or reducing diabetes-related cognitive decline neurodegeneration.<\/jats:p>","DOI":"10.3389\/fcdhc.2026.1791782","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T05:21:18Z","timestamp":1774243278000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Linking inflammation, metabolic dysfunction, and neurodegeneration: a comprehensive review of TLR2 pathways in type 2 diabetes"],"prefix":"10.3389","volume":"7","author":[{"given":"Juan Antonio","family":"Arregu\u00edn-Cano","sequence":"first","affiliation":[{"name":"Faculty of Dentistry, Autonomous University of Chihuahua","place":["Chihuahua, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Aid\u00e9","family":"Santana-Delgado","sequence":"additional","affiliation":[{"name":"Faculty of Dentistry, Autonomous University of Chihuahua","place":["Chihuahua, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Esteban","family":"Villegas-Mercado","sequence":"additional","affiliation":[{"name":"Faculty of Dentistry, Autonomous University of Chihuahua","place":["Chihuahua, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grissel Guadalupe","family":"Orozco-Molina","sequence":"additional","affiliation":[{"name":"Faculty of Dentistry, Autonomous University of Chihuahua","place":["Chihuahua, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Gonz\u00e1lez-Acosta","sequence":"additional","affiliation":[{"name":"Faculty of Dentistry, Autonomous University of Chihuahua","place":["Chihuahua, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Berm\u00fadez","sequence":"additional","affiliation":[{"name":"Faculty of Dentistry, Autonomous University of Chihuahua","place":["Chihuahua, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1538143","article-title":"Global burden and risk factors of type 2 diabetes mellitus from 1990 to 2021, with forecasts to 2050","volume":"16","author":"Huang","year":"2025","journal-title":"Front Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.966093","article-title":"The global burden of type 2 diabetes attributable to high body mass index in 204 countries and territories, 1990-2019: An analysis of the Global Burden of Disease Study","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Public Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","author":"Zhou","year":"2024","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-23-01770","article-title":"Role of metabolic dysfunction and inflammation along the liver-brain axis in animal models with obesity-induced neurodegeneration","volume":"20","author":"Asimakidou","year":"2025","journal-title":"Neural Regener Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00863","article-title":"Environment and gene association with obesity and their impact on neurodegenerative and neurodevelopmental diseases","volume":"14","author":"Flores-Dorantes","year":"2020","journal-title":"Front Neurosci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.999288","article-title":"Metabolic syndrome predictors of brain gray matter volume in an age-stratified community sample of 776 Mexican-American adults: Results from the genetics of brain structure image archive","volume":"14","author":"Kotkowski","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12122841","article-title":"Metabolic dysfunction in Parkinson's disease: Unraveling the glucose-lipid connection","volume":"12","author":"Sian-Hulsmann","year":"2024","journal-title":"Biomedicines"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105488","article-title":"Overnutrition, hyperinsulinemia and ectopic fat: it is time for a paradigm shift in the management of type 2 diabetes","volume":"25","author":"Janssen","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-025-10199-x","article-title":"Neuroinflammaging and the immune landscape: the role of autophagy and senescence in aging brain","volume":"26","author":"Tamatta","year":"2025","journal-title":"Biogerontology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12932","article-title":"Untangling the effect of insulin action on brain mitochondria and metabolism","volume":"33","author":"Schell","year":"2021","journal-title":"J Neuroendocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176253","article-title":"Neutralization of lipocalin-2 diminishes stroke-reperfusion injury","volume":"21","author":"Wang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010132","article-title":"Dysregulation of metabolic peptides in the gut\u2013brain axis promotes hyperinsulinemia, obesity, and neurodegeneration","volume":"13","author":"Green","year":"2025","journal-title":"Biomedicines"},{"key":"B15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.intimp.2018.03.002","article-title":"Toll-like receptors in immunity and inflammatory diseases: Past, present, and future","volume":"59","author":"Vijay","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00329","article-title":"Role of microglia TLRs in neurodegeneration","volume":"12","author":"Fiebich","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02489","article-title":"Human dendritic cell subsets undergo distinct metabolic reprogramming for immune response","volume":"9","author":"Basit","year":"2018","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cells11101663","article-title":"Metabolic reprogramming of innate immune cells as a possible source of new therapeutic approaches in autoimmunity","volume":"11","author":"Mohammadnezhad","year":"2022","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1161\/ATVBAHA.120.314037","article-title":"Metabolic reprogramming in immune response and tissue inflammation","volume":"40","author":"Sun","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S279104","article-title":"Toll-like receptor 4 and inflammatory micro-environment of pancreatic islets in type-2 diabetes mellitus: a therapeutic perspective","volume":"13","author":"Wang","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S499605","article-title":"Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: implications for therapeutic interventions","volume":"14","author":"Berbudi","year":"2025","journal-title":"Immunotargets Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.hsr.2024.100201","article-title":"Deciphering the intricacies of immune system dysfunction and its impact on diabetes mellitus: revisiting the communication strategies to manage diabetes mellitus","volume":"13","author":"Vaibhav","year":"2024","journal-title":"Health Sci Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i4.598","article-title":"Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition","volume":"6","author":"Hameed","year":"2015","journal-title":"World J Diabetes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.901616","article-title":"The role of interleukin-1\u03b2 in type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"27","author":"Alfadul","year":"2022","journal-title":"Front Media"},{"key":"B26","doi-asserted-by":"publisher","first-page":"16348","DOI":"10.1038\/s41598-025-00843-4","article-title":"TLR2 promotes the progression of diabetes mellitus with atherosclerosis via activating NLRP3 inflammasome and MyD88\/NF-\u03baB signaling pathway","volume":"15","author":"Chen","year":"2025","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.5607\/en.2014.23.2.138","article-title":"A decade of research on TLR2 discovering its pivotal role in glial activation and neuroinflammation in neurodegenerative diseases","volume":"23","author":"Hayward","year":"2014","journal-title":"Exp Neurobiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s42269-019-0227-2","article-title":"Toll-like receptors activation, signaling, and targeting: an overview","volume":"43","author":"El-Zayat","year":"2019","journal-title":"Bull Natl Res Centre\/Bulletin Natl Res Center"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M513304200","article-title":"Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes","volume":"281","author":"Senn","year":"2006","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes","volume":"16","author":"Scheithauer","year":"2020","journal-title":"Front Media"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.013","article-title":"Regulating metabolic inflammation by nutritional modulation","volume":"146","author":"Charles\u2010Messance","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/dmsott.s9089","article-title":"Type 2 diabetes mellitus and inflammation: prospects for biomarkers of risk and nutritional intervention","volume":"26","author":"Badawi","year":"2010","journal-title":"Diabetes Metab Syndrome Obes"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.14341\/DM12746","article-title":"Some mechanisms of inflammation development in type 2 diabetes mellitus","volume":"24","author":"\u0411\u043e\u0447\u043a\u0430\u0440\u0435\u0432\u0430","year":"2021","journal-title":"Diabetes Mellitus"},{"key":"B34","volume-title":"IntechOpen eBooks","author":"Tripathi","year":"2022"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225073","article-title":"Next generation sequencing and RNA-seq characterization of adipose tissue in the Nile crocodile (Crocodylus niloticus) in South Africa: possible mechanism(s) of pathogenesis and pathophysiology of pansteatitis","volume":"14","author":"Azeez","year":"2019","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1052756","article-title":"Role of the inflammasome in insulin resistance and type 2 diabetes mellitus","volume":"14","author":"Lu","year":"2023","journal-title":"Front Media"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-021-00446-0","article-title":"Gut microbiota influence in type 2 diabetes mellitus (T2DM)","volume":"6","author":"Cunningham","year":"2021","journal-title":"BioMed Cent"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.15403\/jgld-4248","volume-title":"Enhancing metformin effects by adding gut microbiota modulators to ameliorate the metabolic status of obese, insulin-resistant hosts","author":"Seicaru","year":"2022"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2012.00181","article-title":"Implication of inflammatory signaling pathways in obesity-induced insulin resistance","volume":"3","author":"Tanti","year":"2013","journal-title":"Front Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14241-7","article-title":"The impact of Rhodiola rosea on biomarkers of diabetes, inflammation, and microbiota in a leptin receptor-knockout mouse model","volume":"12","author":"Jafari","year":"2022","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.609223","article-title":"Patterns of toll-like receptor expressions and inflammatory cytokine levels and their implications in the progress of insulin resistance and diabetic nephropathy in type 2 diabetic patients","volume":"11","author":"Aly","year":"2020","journal-title":"Front Physiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052229","article-title":"The role of TLRs in obesity and its related metabolic disorders","volume":"26","author":"Campos-Bayardo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s43556-025-00305-3","article-title":"Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy","volume":"6","author":"Lin","year":"2025","journal-title":"Mol BioMed"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.003044","article-title":"Detection of mitochondria-generated reactive oxygen species in cells using multiple probes and methods: potentials, pitfalls, and the future","volume":"293","author":"Cheng","year":"2018","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1006376","article-title":"Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management","volume":"13","author":"Dini\u0107","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2337\/db20-0591","article-title":"Toll-like receptor 2 (TLR2) knockout abrogates diabetic and obese phenotypes while restoring endothelial function via inhibition of NOX1","volume":"70","author":"Guo","year":"2021","journal-title":"Diabetes"},{"key":"B48","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41392-025-02371-z","article-title":"Immunosenescence: signaling pathways, diseases and therapeutic targets","volume":"10","author":"Fu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/proteomes13030039","article-title":"Adiposome proteomics uncover molecular signatures of cardiometabolic risk in obese individuals","volume":"13","author":"Rakab","year":"2025","journal-title":"Proteomes"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2025.08.005","article-title":"Metabolic hallmarks of type 2 diabetes compromise T cell function","volume":"23","author":"Liang","year":"2025","journal-title":"Trends Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.20944\/preprints201805.0264.v1","article-title":"Endoplasmic reticulum stress in metabolic disorders","volume":"7","author":"Ghemrawi","year":"2018","journal-title":"Cells"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.22074\/cellj.2019.5540","article-title":"Toll-like receptor 2 (TLR-2) gene polymorphisms in type 2 diabetes mellitus","volume":"20","author":"Ermi\u015f Karaali","year":"2019","journal-title":"Cell J"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2025.101386","article-title":"The role of free fatty acid receptors activation in pancreatic disorders","volume":"104","author":"Lis","year":"2025","journal-title":"Mol Aspects Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00566.2012","article-title":"Insulin infusion suppresses while glucose infusion induces toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients","volume":"304","author":"Dandona","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116793","article-title":"Microbiota determines insulin sensitivity in TLR2-KO mice","volume":"234","author":"Guadagnini","year":"2019","journal-title":"Life Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.13702\/j.1000-0607.20240625","article-title":"Electroacupuncture improves glucose and lipid metabolism disorders in diabetic obese rats via PI3K\/Akt\/GLUT4 pathway","volume":"50","author":"Liu","year":"2025","journal-title":"Zhen Ci Yan Jiu"},{"key":"B58","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1677\/JOE-08-0354","article-title":"Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet","volume":"199","author":"Caricilli","year":"2008","journal-title":"J Endocrinol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.23736\/S0031-0808.20.03879-3","article-title":"Type 3 diabetes (Alzheimer's disease): new insight for promising therapeutic avenues","volume":"62","author":"Candasamy","year":"2020","journal-title":"Panminerva Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-020-03031-0","article-title":"Role of insulin resistance in the Alzheimer's disease progression","volume":"45","author":"Nguyen","year":"2020","journal-title":"Neurochem Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189069","article-title":"Microglial dysfunction and amyloid-beta pathology in Alzheimer\u2019s disease and HIV-associated neurocognitive disorders","volume":"26","author":"Njoku","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4172\/2329-6887.1000125","article-title":"Diabetes mellitus and blood-brain barrier dysfunction: An overview","volume":"2","author":"Prasad","year":"2014","journal-title":"J Pharmacovigil"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.661838","article-title":"Blood-brain barrier dysfunction amplifies the development of neuroinflammation: Understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction","volume":"15","author":"Takata","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1103416","article-title":"Microglia activation in central nervous system disorders: A review of recent mechanistic investigations and development efforts","volume":"14","author":"Qin","year":"2023","journal-title":"Front Neurol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.856376","article-title":"Microglia in the neuroinflammatory pathogenesis of Alzheimer's disease and related therapeutic targets","volume":"13","author":"Cai","year":"2022","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.24272\/j.issn.2095-8137.2022.289","article-title":"Animal models of Alzheimer's disease: Applications, evaluation, and perspectives","volume":"43","author":"Chen","year":"2022","journal-title":"Zool Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12974-020-01738-z","article-title":"Systemic microbial TLR2 agonists induce neurodegeneration in Alzheimer's disease mice","volume":"17","author":"Lax","year":"2020","journal-title":"J Neuroinflamm"},{"key":"B68","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","article-title":"Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus","volume":"17","author":"Bettcher","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40364-024-00624-7","article-title":"The role of macrophage plasticity in neurodegenerative diseases","volume":"12","author":"Ma","year":"2024","journal-title":"biomark Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1508726","article-title":"Xixin decoction's novel mechanism for alleviating Alzheimer's disease cognitive dysfunction by modulating amyloid-\u03b2 transport across the blood-brain barrier to reduce neuroinflammation","volume":"15","author":"Yang","year":"2024","journal-title":"Front Pharmacol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-023-02122-1","article-title":"Association between Wnt target genes and cortical volumes in Alzheimer's disease","volume":"73","author":"Dong","year":"2023","journal-title":"J Mol Neurosci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11111373","article-title":"TLR-mediated signal transduction and neurodegenerative disorders","volume":"11","author":"Adhikarla","year":"2021","journal-title":"Brain Sci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13237243","article-title":"Alpha-synuclein and microglia in Parkinson's disease: From pathogenesis to therapeutic prospects","volume":"13","author":"Eo","year":"2024","journal-title":"J Clin Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01007-8","article-title":"LRRK2 ablation attenuates \u03b1lpha-synuclein-induced neuroinflammation without affecting neurodegeneration or neuropathology in vivo","volume":"18","author":"Van der Perren","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B75","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41574-021-00575-1","article-title":"Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities","volume":"18","author":"SantaCruz-Calvo","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2185","article-title":"Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: Further evidence of a proinflammatory state","volume":"93","author":"Devaraj","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1799","article-title":"Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects","volume":"33","author":"Dasu","year":"2010","journal-title":"Diabetes Care"},{"key":"B78","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1038\/s41598-017-07230-8","article-title":"Analysis of inflammatory cytokine and TLR expression levels in type 2 diabetes with complications","volume":"7","author":"Gupta","year":"2017","journal-title":"Sci Rep"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00482.2016","article-title":"TLR2 knockout protects against diabetes-mediated changes in cerebral perfusion and cognitive deficits","volume":"312","author":"Hardigan","year":"2017","journal-title":"Am J Physiol Regul Intgr Comp Physiol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk3674","article-title":"CSF biomarkers of immune activation and Alzheimer\u2019s disease for predicting cognitive impairment risk in the elderly","volume":"10","author":"Shue","year":"2024","journal-title":"Sci Adv"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1192602","article-title":"Cognitive dysfunction in diabetes: abnormal glucose metabolic regulation in the brain","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Media"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19040942","article-title":"Role of inflammation in diabetic retinopathy","volume":"22","author":"R\u00fcbsam","year":"2018","journal-title":"Multidiscip Digital Publishing Institute"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s12529-024-10274-6","article-title":"The effects of type 2 diabetes on cognitive performance: A review of reviews","volume":"31","author":"Sola","year":"2024","journal-title":"Springer Science+Business Media"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.602501","article-title":"White matter atrophy in type 2 diabetes mellitus patients with mild cognitive impairment","volume":"14","author":"Li","year":"2021","journal-title":"Front Neurosci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116144","article-title":"Diagnostic, prognostic, and mechanistic biomarkers of diabetes mellitus-associated cognitive decline","volume":"23","author":"Ehtewish","year":"2022","journal-title":"Multidiscip Digital Publishing Institute"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.686838","article-title":"Elevated peripheral brain-derived neurotrophic factor level associated with decreasing insulin secretion may forecast memory dysfunction in patients with long-term type 2 diabetes","volume":"12","author":"Huang","year":"2022","journal-title":"Front Physiol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1747-3","article-title":"Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet","volume":"53","author":"Ehses","year":"2010","journal-title":"Diabetologia"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2022.05.004","article-title":"Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions","volume":"43","author":"Squillace","year":"2022","journal-title":"Elsevier BV"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-021-03365-3","article-title":"Toll-like receptor 2 antagonist ameliorates type 2 diabetes mellitus associated neuropathic pain by repolarizing pro-inflammatory macrophages","volume":"46","author":"Tian","year":"2021","journal-title":"Neurochem Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132575","article-title":"Pharmacological TLR4 inhibition protects against acute and chronic fat-induced insulin resistance in rats","volume":"10","author":"Zhang","year":"2015","journal-title":"PloS One"},{"key":"B91","doi-asserted-by":"publisher","first-page":"19350","DOI":"10.1038\/s41598-019-55521-z","article-title":"Toll-like receptor 4 inhibition prevents autoimmune diabetes in NOD mice","volume":"9","author":"Alibashe-Ahmed","year":"2019","journal-title":"Sci Rep"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162291","article-title":"Effect of acute TLR4 inhibition on insulin resistance in humans","volume":"132","author":"Liang","year":"2022","journal-title":"J Clin Invest"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-019-00289-w","article-title":"Polyphenols for diabetes associated neuropathy: Pharmacological targets and clinical perspective","volume":"21","author":"Naseri","year":"2019","journal-title":"Springer Nat"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2021.0318","article-title":"Targeting NLRP3 inflammasome in the treatment of diabetes and diabetic complications: Role of natural compounds from herbal medicine","volume":"12","author":"Bai","year":"2021","journal-title":"Buck Institute Res Aging"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/plants11040549","article-title":"Natural products as novel neuroprotective agents; computational predictions of the molecular targets, ADME properties, and safety profile","volume":"11","author":"Alghamdi","year":"2022","journal-title":"Plants"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020235","article-title":"The use of bioactive compounds in hyperglycemia- and amyloid fibrils-induced toxicity in type 2 diabetes and Alzheimer\u2019s disease","volume":"20","author":"Lup\u0103escu","year":"2022","journal-title":"Multidiscip Digital Publishing Institute"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12010132","article-title":"Redox remodeling by nutraceuticals for prevention and treatment of acute and chronic inflammation","volume":"5","author":"Petrarca","year":"2023","journal-title":"Multidiscip Digital Publishing Institute"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-025-04455-7","article-title":"Repurposing the hypoglycaemic agents for neuroinflammation, a comprehensive review","volume":"15","author":"Blossom","year":"2025","journal-title":"Springer Science+Business Media"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.754123","article-title":"The anti-diabetic drug gliquidone modulates lipopolysaccharide-mediated microglial neuroinflammatory responses by inhibiting the NLRP3 inflammasome","volume":"13","author":"Kim","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci9030057","article-title":"Empagliflozin ameliorates type 2 diabetes-induced ultrastructural remodeling of the neurovascular unit and neuroglia in the female db\/db mouse","volume":"9","author":"Hayden","year":"2019","journal-title":"Brain Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.547175","article-title":"Role of insulin in neurotrauma and neurodegeneration","volume":"21","author":"Shaughness","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150493","article-title":"Metformin in amnestic mild cognitive impairment: Results of a pilot randomized placebo controlled clinical trial","volume":"51","author":"Luchsinger","year":"2016","journal-title":"J Alzheimer\u2019s Dis"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180263","article-title":"Metformin use associated with reduced risk of dementia in patients with diabetes: A systematic review and meta-analysis","volume":"65","author":"Campbell","year":"2018","journal-title":"J Alzheimer\u2019s Dis"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1159\/000318845","article-title":"Rosiglitazone monotherapy in mild-to-moderate Alzheimer\u2019s disease","volume":"30","author":"Gold","year":"2010","journal-title":"Dementia Geriatric Cogn Disord"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00043-0","article-title":"Safety and efficacy of pioglitazone for prevention of cognitive impairment in people at risk of Alzheimer\u2019s disease (TOMMORROW)","volume":"20","author":"Burns","year":"2021","journal-title":"Lancet Neurol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010036","article-title":"SGLT2 inhibitor canagliflozin alleviates high glucose-induced inflammatory toxicity in BV-2 microglia","volume":"12","author":"Lee","year":"2023","journal-title":"Biomedicines"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2015.01.052","article-title":"Acarbose improves behavioral and biochemical changes in SAMP8 mice","volume":"278","author":"Tong","year":"2015","journal-title":"Behav Brain Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01337-3","article-title":"Acarbose ameliorates metabolic and cognitive dysfunction in 3xTg-AD mice","volume":"23","author":"Sonsalla","year":"2024","journal-title":"Aging Cell"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/alz.057848","article-title":"Liraglutide in Alzheimer\u2019s disease (ELAD study)","volume":"17","author":"Femminella","year":"2021","journal-title":"Alzheimer\u2019s Dementia"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2024-335593","article-title":"GLP-1 receptor agonists as disease-modifying therapies for Alzheimer\u2019s disease","volume":"28","author":"Nowell","year":"2023","journal-title":"Mol Psychiatry"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2016.12.010","article-title":"The effects of sitagliptin on cognitive function in elderly patients with type 2 diabetes","volume":"127","author":"Isik","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228750","article-title":"Linagliptin reduces microglial activation in diabetic model mice","volume":"15","author":"Ide","year":"2020","journal-title":"PloS One"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411450","article-title":"Repositioning of anti-diabetic drugs against dementia: Insight from molecular perspectives to clinical trials","volume":"14","author":"Mantik","year":"2023","journal-title":"Multidiscip Digital Publishing Institute"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S274844","article-title":"Toll-like receptors as a potential drug target for diabetes mellitus and diabetes-associated complications","volume":"4","author":"As","year":"2020","journal-title":"DOAJ (DOAJ: Directory Open Access Journals)"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1042\/CS20110357","article-title":"Toll-like receptors and diabetes: a therapeutic perspective","volume":"122","author":"Dasu","year":"2011","journal-title":"Portland Press"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-016-0002-4","article-title":"Toll-like receptor 2 and type 2 diabetes","volume":"28","author":"Sepehri","year":"2016","journal-title":"BioMed Cent"},{"key":"B117","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2010.11.011","article-title":"The inflammasome mediates obesity-induced inflammation and insulin resistance","volume":"14","author":"Stienstra","year":"2011","journal-title":"Cell Metab"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16902","article-title":"Metabolite-derived damage-associated molecular patterns in immunological diseases","volume":"291","author":"Kang","year":"2024","journal-title":"FEBS J"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087007","article-title":"RAGE-TLR4 crosstalk is the key mechanism by which high glucose enhances the lipopolysaccharide-induced inflammatory response in primary bovine alveolar macrophages","volume":"24","author":"Yan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1656165","article-title":"C\/EBP\u03b2 as a master regulator of inflammasome signaling in neurodegenerative diseases: Mechanisms and therapeutic implications","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00018-024-05533-4","article-title":"Innate and adaptive immunity in neurodegenerative disease","volume":"82","author":"Huang","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-015-0130-5","article-title":"The impact of diabetes on cognitive decline: Potential vascular, metabolic, and psychosocial risk factors","volume":"7","author":"Feinkohl","year":"2015","journal-title":"Alzheimer S Res Ther"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1586\/ern.11.152","article-title":"The association of diabetes and dementia and possible implications for nondiabetic populations","volume":"11","author":"Ravona\u2010Springer","year":"2011","journal-title":"Taylor Francis"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.03.06.dc05-1901","article-title":"Diabetes and function in different cognitive systems in older individuals without dementia","volume":"29","author":"Arvanitakis","year":"2006","journal-title":"Diabetes Care"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.1070611","article-title":"Cognitive impairment with type 2 diabetes mellitus among community-dwelling older adults in Chile: Prevalence, risk factors and cognitive characteristics","volume":"16","author":"Bozanic","year":"2023","journal-title":"Front Hum Neurosci"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00856","article-title":"Type 2 diabetes mellitus may exacerbate gray matter atrophy in patients with early-onset mild cognitive impairment","volume":"14","author":"Li","year":"2020","journal-title":"Front Neurosci"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c170019","article-title":"Impact of metabolic diseases on cerebral circulation: Structural and functional consequences","volume":"8","author":"Coucha","year":"2018","journal-title":"Wiley"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.860122","article-title":"Identification of TLR2 as a key target in neuroinflammation in vascular dementia","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.874007","article-title":"Neurovascular coupling in type 2 diabetes with cognitive decline. A narrative review of neuroimaging findings and their pathophysiological implications","volume":"13","author":"Barloese","year":"2022","journal-title":"Front Endocrinol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59071337","article-title":"Brain injury: Response to injury wound-healing mechanisms and enlarged perivascular spaces in obesity, metabolic syndrome, and type 2 diabetes mellitus","volume":"59","author":"Hayden","year":"2023","journal-title":"Medicina"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1375908","article-title":"The role of neurovascular coupling dysfunction in cognitive decline of diabetes patients","volume":"18","author":"Feng","year":"2024","journal-title":"Front Neurosci"},{"key":"B134","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12877-022-03151-y","article-title":"Type 2 diabetes mellitus and cognitive decline in older adults in Germany \u2013 Results from a population-based cohort","volume":"22","author":"Xie","year":"2022","journal-title":"BMC Geriatrics"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160114","article-title":"An update on type 2 diabetes mellitus as a risk factor for dementia","volume":"3","author":"Li","year":"2016","journal-title":"IOS Press"},{"key":"B136","doi-asserted-by":"publisher","first-page":"24","DOI":"10.33483\/jfpau.1505825","article-title":"IL-6 levels and cognitive complications in patients with type 2 diabetes mellitus: A cross sectional study","volume":"48","author":"\u0130vecek","year":"2024","journal-title":"Ankara Universitesi Eczacilik Fakultesi Dergisi"},{"key":"B137","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3126\/ajms.v13i9.44379","article-title":"A study to evaluate the relationship between diabetes mellitus and cognitive dysfunction","volume":"13","author":"Patel","year":"2022","journal-title":"Asian J Med Sci"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S465103","article-title":"Aberrant neurovascular coupling in diabetic retinopathy using arterial spin labeling (ASL) and functional magnetic resonance imaging (fMRI) methods","volume":"26","author":"Li","year":"2024","journal-title":"Diabetes Metab Syndrome Obes"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1418714","article-title":"Functional connectivity density aberrance in type 2 diabetes mellitus with and without mild cognitive impairment","volume":"15","author":"Ge","year":"2024","journal-title":"Front Neurol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.933833","article-title":"Endothelin and diabetic complications: A brain-centric view","volume":"27","author":"Li","year":"2018","journal-title":"Institute Physiol Czech Acad Sci"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170046","article-title":"Can better management of periodontal disease delay the onset and progression of Alzheimer\u2019s disease","volume":"58","author":"Harding","year":"2022","journal-title":"Adv Alzheimer's disease: IOS Press"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68299-2","article-title":"The innate immune toll-like-receptor-2 modulates the depressogenic and anorexiolytic neuroinflammatory response in obstructive sleep apnoea","volume":"10","author":"Pol\u0161ek","year":"2020","journal-title":"Sci Rep"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160397","article-title":"Cerebrovascular complications of diabetes: Focus on cognitive dysfunction","volume":"10","author":"Hardigan","year":"2016","journal-title":"Portland Press"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2019-0105","article-title":"Cognitive impairments in type 2 diabetes, risk factors and preventive strategies","volume":"22","author":"Sharma","year":"2020","journal-title":"Gruyter"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1791782\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T05:21:22Z","timestamp":1774243282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1791782\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":144,"alternative-id":["10.3389\/fcdhc.2026.1791782"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2026.1791782","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"article-number":"1791782"}}